| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/25/2004 | CN1477967A Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 02/25/2004 | CN1477961A Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1477100A Compound with activity for resisting platelet agregation and its preparation method |
| 02/25/2004 | CN1476891A Chinese medicine composition for curing apoplexy and its preparation method |
| 02/25/2004 | CN1476883A Medicine for fumigating and washing anal disease |
| 02/25/2004 | CN1476849A Medicine composition for promoting blood circulation and removing stasis |
| 02/25/2004 | CN1476841A Puerarin dispersing tablet composition and its preparation method |
| 02/25/2004 | CN1476840A Preparation method of stable fleabane extract injection |
| 02/25/2004 | CN1476838A High-activity ginkgo leaf extract preparation and application |
| 02/25/2004 | CN1476833A Preparation method of medicine for curing urteriosclerosis by using CS-866, losartan and candisartan |
| 02/25/2004 | CN1476832A Bilobalide soft capsule and its preparation method |
| 02/25/2004 | CN1476830A Tea-polyphenol soft capsule and its preparation process |
| 02/25/2004 | CN1476828A Suspended preparation of biguanide vanadium complex-medicine for curing diabetes and its application |
| 02/25/2004 | CN1139599C Process for prepaing pharmacologically acceptable salts of N-(1-(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids |
| 02/25/2004 | CN1139588C Novel fluorinated imidazoline benzodioxane, preparation and therapeutic use thereof |
| 02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
| 02/25/2004 | CN1139579C Isoxazolecarboxamide derivatives |
| 02/25/2004 | CN1139570C Inhibition of matrix metalloproteases by acetylene-containing compound |
| 02/25/2004 | CN1139401C Artificial cornu rhinocerotis-golssy ganoderma ointment |
| 02/25/2004 | CN1139380C Water based externally used cream containing nitroglycerin, and prepn method and use thereof |
| 02/24/2004 | US6697668 Ocular iontophoretic device and method for using the same |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696556 Genetic engineering |
| 02/24/2004 | US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure |
| 02/24/2004 | US6696474 Such as 8-(5-methyl-2-phenyl-oxazol-4-yl)-2-pyrrol-1-yl-oct-4-ynoic acid; noninsulin dependent diabetes mellitus |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes |
| 02/24/2004 | US6696467 Quinoline derivatives |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696457 Morphinoid compounds |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696446 Benzoylpyridazines, their preparation and use |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696444 Neurotransmitter antagonists comprising compounds such as 4,2'-difluoro-5'-(3-(1-fluoro-1-methylethyl)imidazo(1,2-b)(1,2 ,4) triazin-7-yl)biphenyl-2-carbonitrile, administered for the prophylaxis of headaches or as anticonvulsants |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
| 02/24/2004 | US6696434 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 02/24/2004 | US6696427 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 02/24/2004 | US6696408 Administering glycosylated polypeptides as antiepileptics and anticonvulsants or for prophylaxis of psychological disorders |
| 02/24/2004 | CA2293461C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/24/2004 | CA2114542C Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists |
| 02/23/2004 | CA2399630A1 Scyphostatin analogues as smase inhibitors |
| 02/21/2004 | CA2437664A1 Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| 02/19/2004 | WO2004015125A1 Process for preparing peptides with anti-hypertensive properties |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015100A1 Method of judging inflammatory disease |
| 02/19/2004 | WO2004015096A2 Leech extracts for stents |
| 02/19/2004 | WO2004014932A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 02/19/2004 | WO2004014927A1 Mitochondrially targeted antioxidants |
| 02/19/2004 | WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | WO2004014915A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 02/19/2004 | WO2004014913A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014911A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014910A1 Dihydropyrazolopyridine compounds |
| 02/19/2004 | WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 02/19/2004 | WO2004014892A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014880A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014873A1 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof |
| 02/19/2004 | WO2004014866A1 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014861A1 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof |
| 02/19/2004 | WO2004014859A2 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | WO2004014849A2 Isosorbide mononitrate compositions and methods of their use |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014843A1 Substituted amino compounds and use thereof |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014427A1 Medicinal composition for lowering blood lipid level |
| 02/19/2004 | WO2004014426A1 Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer |
| 02/19/2004 | WO2004014425A1 Activators of small conductance calcium activated potassium channels and use thereof |
| 02/19/2004 | WO2004014415A1 Growth hormone releasing peptides |
| 02/19/2004 | WO2004014414A1 Novel uses of rfrp and ot7t022 |
| 02/19/2004 | WO2004014412A1 Myocardial cell protecting agents |
| 02/19/2004 | WO2004014410A1 Composition comprising the extract of cistanche deserticola y.c. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects |
| 02/19/2004 | WO2004014396A1 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |
| 02/19/2004 | WO2004014395A1 Female hormone-containing patch |
| 02/19/2004 | WO2004014374A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/19/2004 | WO2004014372A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | WO2004014359A1 Regulation of apob in treatment and drug screening for cardiovascular and metabolic disorders or syndromes |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2004014343A1 Storage stable tablets of fosinopril sodium |
| 02/19/2004 | WO2004014304A2 Electrospun amorphous pharmaceutical compositions |
| 02/19/2004 | WO2004014298A2 Composition and method for lowering cholesterol |
| 02/19/2004 | WO2004014222A2 Diagnosis and treatment of tuberous sclerosis |
| 02/19/2004 | WO2004014151A1 Cereal based food product comprising dha and/or epa |
| 02/19/2004 | WO2004014150A1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 02/19/2004 | WO2004007478A3 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 02/19/2004 | WO2004007430A3 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 02/19/2004 | WO2004000840A3 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 02/19/2004 | WO2003104473A3 Galactosyl isomalt, method for production and use thereof |
| 02/19/2004 | WO2003087318A3 Truncated 24 kda basic fibroblast growth factor |